ARS Pharmaceuticals CEO to participate in upcoming investor conferences
ARS Pharmaceuticals said Donn Casale, President and CEO, will participate in upcoming investor conferences, according to a company announcement.
SAN DIEGO, Sept.
01, 2026 (GLOBE NEWSWIRE) -- ARS Pharmaceuticals, Inc.
NASDAQ:SPRY, a biopharmaceutical company dedicated to empowering at-risk patients and their caregivers to treat and prevent severe allergic reactions, today announced that Donn Casale, President and CEO, will participate in the…